RT @drgandara: Interesting but not sure how generalizable this case is? https://t.co/VOz6k4FYW3
RT @larshaakon: Wow. First case report, from China, showing NSCLC patient with the three EGFR mutation L858R, T790M and C797S (in cis) resp…
RT @drgandara: Interesting but not sure how generalizable this case is? https://t.co/VOz6k4FYW3
Interesting but not sure how generalizable this case is?
RT @larshaakon: Wow. First case report, from China, showing NSCLC patient with the three EGFR mutation L858R, T790M and C797S (in cis) resp…
Wow. First case report, from China, showing NSCLC patient with the three EGFR mutation L858R, T790M and C797S (in cis) responding to a combination of osimertinib and brigatinib (and bevacizumab). #LCSM @EGFRResisters Thoughts, @drgandara @JackWestMD? https